Clinical trials
Active, not recruiting Head and Neck Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| Merus B.V. | 2 |
| BioNTech SE | 1 |
| Centre Oscar Lambret | 1 |
| Checkpoint Therapeutics, Inc. | 1 |
| Exelixis | 1 |
| GlaxoSmithKline | 1 |
| Groupe Oncologie Radiotherapie Tete et Cou | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Colorectal Neoplasms | 6 |
| Neoplasms | 6 |
| Carcinoma, Renal Cell | 5 |
| Lung Neoplasms | 4 |
| Melanoma | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Transitional Cell | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.